IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q2 2025 Holdings

Filed 2025-08-08 | 3 holdings | $163.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tango Therapeutics, Inc.(TNGX)COM87583X109$86.3M16,859,07552.9%
Maze Therapeutics, Inc.(MAZE)COM578784100$74.5M6,073,95845.6%
Pliant Therapeutics, Inc.(PLRX)COM729139105$2.5M2,132,8671.5%